Novo Nordisk A/S (NVO)

Novo Nordisk Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	14,392	12,653	10,720	12,757	15,475
Short-Term Investments	15,838	10,921	6,765	0	0
Cash & Cash Equivalents	30,230	23,574	17,485	12,757	15,475
Cash Growth	28.23%	34.82%	37.06%	-17.56%	-1.04%
Receivables	64,770	50,560	40,643	27,734	24,912
Inventory	31,811	24,388	19,621	18,536	17,641
Other Current Assets	12,835	9,672	7,846	6,782	4,428
Total Current Assets	139,646	108,194	85,595	65,809	62,456
Property, Plant & Equipment	90,961	66,671	55,362	50,269	50,551
Long-Term Investments	1,663	1,343	1,441	1,648	1,808
Goodwill and Intangibles	60,406	50,939	43,171	20,657	5,835
Other Long-Term Assets	21,810	14,110	8,939	6,539	4,962
Total Long-Term Assets	174,840	133,063	108,913	79,113	63,156
Total Assets	314,486	241,257	194,508	144,922	125,612
Accounts Payable	25,606	15,587	8,870	5,717	6,358
Current Debt	6,478	1,466	13,684	7,459	1,474
Other Current Liabilities	137,571	103,887	76,962	57,097	51,151
Total Current Liabilities	169,655	120,940	99,516	70,273	58,983
Long-Term Debt	20,528	24,318	12,961	2,897	3,009
Other Long-Term Liabilities	17,742	12,513	11,285	8,427	6,027
Total Long-Term Liabilities	38,270	36,831	24,246	11,324	9,036
Total Liabilities	207,925	157,771	123,762	81,597	68,019
Total Debt	27,006	25,784	26,645	10,356	4,483
Debt Growth	4.74%	-3.23%	157.29%	131.01%	770.49%
Retained Earnings	104,839	80,587	72,004	63,774	57,817
Shareholders' Equity	106,561	83,486	70,746	63,325	57,593
Net Cash / Debt	3,224	-2,210	-9,160	2,401	10,992
Net Cash / Debt Growth	-	-	-	-78.16%	-27.32%
Working Capital	-30,009	-12,746	-13,921	-4,464	3,473
Book Value Per Share	23.37	18.46	15.43	13.43	11.75

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).